非创伤患者开腹与一期关腹:单中心经验的加权分析
该单中心回顾性研究纳入2017年至2023年的320例急诊开腹手术患者,其中一期关腹167例、开腹153例,采用逆概率加权平衡两组差异。加权后90天生存率一期关腹组为50.8%,开腹组为60.8%(HR 0.79,95%CI 0.40-1.55,p=0.502),开腹未增加并发症率或死亡率,但住院时间更长。Cox回归显示临床衰弱量表评分(HR 1.125,95%CI 1.01-1.25,p=0.033)和肠缺血(HR 5.531,95%CI 2.37-12.89,p<0.001)为死亡的独立危险因素。在肠缺血亚组中,开腹(HR 0.056,95%CI 0.01-0.22,p=0.001)和大肠切除(HR 6.442,95%CI 1.28-32.31,p=0.040)是更长生存的预测因素。
要点
- 加权后90天生存率一期关腹组50.8% vs 开腹组60.8%,HR 0.79(95%CI 0.40-1.55,p=0.502),差异未达统计学显著。
- 开腹未增加主要并发症率,但导致住院时间更长(原文结论)。
- 肠缺血是死亡的独立危险因素(HR 5.531,95%CI 2.37-12.89,p<0.001);临床衰弱量表评分每增加1分,死亡风险HR 1.125(95%CI 1.01-1.25,p=0.033)。
- 在肠缺血亚组中,开腹与更长生存相关(HR 0.056,95%CI 0.01-0.22,p=0.001),大肠切除与更长生存相关(HR 6.442,95%CI 1.28-32.31,p=0.040)。
- 输血率(OR 3.44,95%CI 1.44-8.23,p<0.006)和ICU住院时长(OR 1.13,95%CI 1.07-1.20,p<0.001)与主要并发症相关。
适用人群与场景
- 2017年至2023年接受急诊开腹手术的非创伤患者,共320例(一期关腹167例,开腹153例)。
- 亚组分析人群包括曼海姆腹膜炎指数>26、肠梗阻、肠缺血和胃肠道穿孔的患者。
诊断标准与关键阈值
- 曼海姆腹膜炎指数(MPI)>26作为亚组分析阈值。
- 临床衰弱量表(Clinical Frailty Scale)评分作为连续变量纳入Cox回归。
研究设计与关键结果
- 研究类型:单中心回顾性分析,纳入2017年至2023年急诊开腹手术患者320例,采用逆概率加权平衡组间差异。
- 主要终点:加权后90天生存率一期关腹组50.8% vs 开腹组60.8%,HR 0.79(95%CI 0.40-1.55,p=0.502)。
- Cox回归:临床衰弱量表评分HR 1.125(95%CI 1.01-1.25,p=0.033)和肠缺血HR 5.531(95%CI 2.37-12.89,p<0.001)为死亡的独立危险因素。
- 主要并发症相关因素:输血率OR 3.44(95%CI 1.44-8.23,p<0.006),ICU住院时长OR 1.13(95%CI 1.07-1.20,p<0.001)。
- 亚组分析:开腹未改变肠梗阻、MPI>26或胃肠道穿孔患者的死亡率;在肠缺血亚组中,开腹(HR 0.056,95%CI 0.01-0.22,p=0.001)和大肠切除(HR 6.442,95%CI 1.28-32.31,p=0.040)是更长生存的预测因素。
- 开腹未导致更高的并发症率或死亡率,但导致住院时间更长。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究,证据等级为预后与流行病学Level III(原文标注)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在非创伤急诊开腹手术患者中,开腹策略未显示生存获益(HR 0.79,95%CI 0.40-1.55,p=0.502),但住院时间更长,提示需权衡开腹的获益与住院时间延长。
- 在肠缺血患者中,开腹似乎具有生存优势(HR 0.056,95%CI 0.01-0.22,p=0.001),作者认为开腹可能仅在该人群中有益。
- 临床衰弱量表评分较高(HR 1.125,95%CI 1.01-1.25,p=0.033)和肠缺血(HR 5.531,95%CI 2.37-12.89,p<0.001)提示死亡风险增加,应加强监护。
- 输血率(OR 3.44,95%CI 1.44-8.23,p<0.006)和ICU住院时长(OR 1.13,95%CI 1.07-1.20,p<0.001)与主要并发症相关,可作为风险分层参考。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The open abdomen (OA) technique is nowadays a worldwide strategy both for trauma and emergency general surgery. Despite the attempt at conducting prospective studies, a high level of evidence is far from established. The aim of this study was to investigate if we overused this strategy and if it improved the postoperative course of our patients.
METHODS: Emergency laparotomies from 2017 and 2023 were reviewed and stratified according to OA and closed abdomen (CA). Differences were balanced by inverse probability weighting, and the 90-day mortality was estimated. Subgroup analysis was carried out for patients with a Mannheim Peritonitis Index (MPI) of >26, bowel obstruction, bowel ischemia (BI) and gastrointestinal perforation.
RESULTS: Of the 320 patients, 167 were CA and 153 were OA. Groups were different for American Society of Anesthesiologists, comorbidities, transfusion rate, Physiologic and Operative Severity Score for the Study of Mortality and Morbidity score, MPI, Clinical Frailty Scale score, diagnosis, and resection. Two balanced pseudo-populations were created. The 90-day survival rate was 50.8% for CA and 60.8% for OA (hazard ratio [HR], 0.79; confidence interval [CI], 0.40-1.55; p = 0.502). At the Cox regression, the Clinical Frailty Scale score (HR, 1.125; 95% CI, 1.01-1.25; p = 0.033) and BI (HR, 5.531; 95% CI, 2.37-12.89; p < 0.001) were independent risk factors for mortality. Transfusion rate (odds ratio [OR], 3.44; 95% CI, 1.44-8.23; p < 0.006) and length of stay in the intensive care unit (OR, 1.13; 95% CI, 1.07-1.20; p < 0.001) were associated with major complications. Open abdomen did not modify mortality in the case of bowel obstruction, MPI >26, or gastrointestinal perforation. Finally, OA (HR, 0.056; 95% CI, 0.01-0.22; p = 0.001) and large bowel resection (HR, 6.442; 95% CI, 1.28-32.31; p = 0.040) were predictors of longer survival in the subgroup of patients with BI.
CONCLUSION: Open abdomen was not associated with a higher complication rate or higher mortality but did result in a longer in-hospital stay. The only setting where OA seemed to be advantageous was in the BI population.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.
参考来源
- Bunino FM, Zulian D, Famularo S, et al. Open abdomen versus primary closure in nontrauma patients: A weighted analysis of a single-center experience. J Trauma Acute Care Surg. 2024. PMID: 40013921. doi:10.1097/TA.0000000000004488
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。